Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Clinical trial NCT06990529 · RECRUITING
Trial details
- NCT number
- NCT06990529
- Sponsor
- Pharming Technologies B.V.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2028-09-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.